Answers are grounded in this paper and cite their sources.
BACKGROUND: (PRAME) might have the potential to uncover the melanocytic origin of these dedifferentiated tumors. METHODS: Four cases of rhabdoid primary melanomas were assessed by immunohistochemistry for expression of PRAME and conventional melanocytic markers. Immunohistochemical expression patterns were analyzed in the rhabdoid primaries and, if available, associated metastases. RESULTS: All four cases of rhabdoid primary melanomas showed a strong nuclear positivity for PRAME, while the expression of conventional melanocytic markers S100, MART-1, SOX-10 and HMB-45 was variable between the analyzed cases. CONCLUSIONS: In summary, we report four cases of rhabdoid primary melanoma with high to intermediate expression of PRAME despite the partial and variable loss of other melanocytic markers. Hence, PRAME might facilitate the recognition of this highly aggressive entity to avoid misdiagnosis due to histopathologic pitfalls.
No takes yet. Share an insight, caveat, or question.
Glutsch et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: